{"transactions":[{"id":682665,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":22020,"kind":"person","name":"Levin Rami","position":1,"cik":"0002102719","reported_name":"Levin Rami","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-08-18T13:00:03.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date."}],"balance_after":14250,"derivative":{"underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001683168-26-006552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826006552/ownership.xml","form_type":"4"}},{"id":682664,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":22020,"kind":"person","name":"Levin Rami","position":1,"cik":"0002102719","reported_name":"Levin Rami","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-08-18T13:00:03.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001683168-26-006552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826006552/ownership.xml","form_type":"4"}},{"id":954859,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":22020,"kind":"person","name":"Levin Rami","position":1,"cik":"0002102719","reported_name":"Levin Rami","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T22:01:02.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date."}],"balance_after":19000,"derivative":{"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001683168-26-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826000016/ownership.xml","form_type":"4"}}]}